Abeona’s Sanfilippo Gene Therapy Data Produces Encouraging Results – Pharmaceutical Processing
UtahHerald.com |
Abeona's Sanfilippo Gene Therapy Data Produces Encouraging Results
Pharmaceutical Processing Abeona Therapeutics announces new phase 1/2 safety and biopotency data of investigational gene therapy for Sanfilippo syndrome at WORLDSymposium. Abeona Therapeutics Inc., a clinical-stage biopharmaceutical company focused on developing novel cell and … Abeona's gene therapy candidate for Sanfilippo B shows encouraging effect in first patient; shares up 12% Why Abeona Therapeutics Jumped 14% on Wednesday Abeona Therapeutics (ABEO) Given Buy Rating at Maxim Group |
